Used in pharmaceutical research as a potent and selective inhibitor of certain kinases involved in inflammatory and oncogenic signaling pathways. Shows promise in preclinical studies for targeted cancer therapy, particularly in tumors driven by dysregulated kinase activity. Its structure allows for high binding affinity and improved metabolic stability, making it a candidate for oral drug formulations. Also investigated for modulating immune responses in autoimmune diseases due to its ability to cross cell membranes efficiently and exert intracellular effects at low concentrations.